Literature DB >> 16320278

Bayesian back-calculation using a multi-state model with application to HIV.

Michael J Sweeting1, Daniela De Angelis, Odd O Aalen.   

Abstract

Back-calculation is a method of obtaining estimates of the number of infections of a disease over time. Data on an endpoint of the disease, together with knowledge of the time from infection to endpoint, allows reconstruction of the incidence of infection. The technique has had much success when applied to the HIV epidemic, using incidence of AIDS diagnoses to inform past HIV infections. In recent years, the period from infection to AIDS has changed considerably due to new regimes of anti-viral therapies. This has led to attempts to use incidence of first positive HIV test as an alternative basis for back-calculation. Developing on earlier work, this paper explores the feasibility of a multi-state formulation of the back-calculation method that models the disease and diagnosis processes and uses HIV diagnoses as an endpoint. Estimation is carried out in a Bayesian framework, which naturally allows incorporation of external information to inform the diagnosis probabilities. The idea is illustrated on data from the HIV epidemic in homosexuals in England and Wales. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16320278     DOI: 10.1002/sim.2432

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  13 in total

1.  Special issue dedicated to Odd O. Aalen.

Authors:  Ørnulf Borgan; Håkon K Gjessing
Journal:  Lifetime Data Anal       Date:  2019-08-28       Impact factor: 1.588

2.  High percentage of undiagnosed HIV cases within a hyperendemic South African community: a population-based study.

Authors:  Alain Vandormael; Tulio de Oliveira; Frank Tanser; Till Bärnighausen; Joshua T Herbeck
Journal:  J Epidemiol Community Health       Date:  2017-11-24       Impact factor: 3.710

3.  Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men.

Authors:  Justin T Okano; Danielle Robbins; Laurence Palk; Jan Gerstoft; Niels Obel; Sally Blower
Journal:  Lancet Infect Dis       Date:  2016-05-09       Impact factor: 25.071

4.  A Bayesian hierarchical model with novel prior specifications for estimating HIV testing rates.

Authors:  Qian An; Jian Kang; Ruiguang Song; H Irene Hall
Journal:  Stat Med       Date:  2015-11-15       Impact factor: 2.373

5.  Bayesian evidence synthesis for a transmission dynamic model for HIV among men who have sex with men.

Authors:  A M Presanis; D De Angelis; A Goubar; O N Gill; A E Ades
Journal:  Biostatistics       Date:  2011-04-27       Impact factor: 5.899

6.  Estimating HIV incidence from case-report data: method and an application in Colombia.

Authors:  Juan Fernando Vesga; Anne Cori; Ard van Sighem; Timothy B Hallett
Journal:  AIDS       Date:  2014-11       Impact factor: 4.177

7.  Estimation of delay to diagnosis and incidence in HIV using indirect evidence of infection dates.

Authors:  Oliver T Stirrup; David T Dunn
Journal:  BMC Med Res Methodol       Date:  2018-06-27       Impact factor: 4.615

8.  Extending Bayesian back-calculation to estimate age and time specific HIV incidence.

Authors:  Francesco Brizzi; Paul J Birrell; Martyn T Plummer; Peter Kirwan; Alison E Brown; Valerie C Delpech; O Noel Gill; Daniela De Angelis
Journal:  Lifetime Data Anal       Date:  2019-02-27       Impact factor: 1.588

9.  Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy.

Authors:  Rebecca K Lodwick; Fumiyo Nakagawa; Ard van Sighem; Caroline A Sabin; Andrew N Phillips
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data.

Authors:  Ard van Sighem; Fumiyo Nakagawa; Daniela De Angelis; Chantal Quinten; Daniela Bezemer; Eline Op de Coul; Matthias Egger; Frank de Wolf; Christophe Fraser; Andrew Phillips
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.